Literature DB >> 1084243

Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.

M A Scheinberg, E S Cathcart.   

Abstract

Antibody-dependent direct cytotoxicity (ADDC) is generally believed to be unrelated to T-cell function in experimental animals. The role of ADDC in humans and its clinical usefulesss was evaluated in patients with systemic lupus erythematosus (SLE) and normal controls. Peripheral blood lymphocytes from patients with active SLE were unable to lyse antibody-coated target cells in vitro to the same degree as lymphocytes from patients with inactive SLE and controls. Sera from patients with active SLE suppressed ADDC by lymphocytes derived from normal controls and this abnormality was not corrected by overnight incubation or by extensive washing of lymphocyte preparations. Although there was poor correlation between ADDC and the proportions of B cells and null cells in effector lymphocyte populations from SLE patients and controls, it is concluded that this assay provides another means of determining immune competence in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084243      PMCID: PMC1538405     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.

Authors:  A H Greenberg; L Hudson; L Shen; I M Roitt
Journal:  Nat New Biol       Date:  1973-03-28

2.  Cell interactions in humoral and cell-mediated immunity.

Authors:  G Dennert; E Lennox
Journal:  Nat New Biol       Date:  1972-07-26

3.  Target cell death without added complement after cooperation of 7S antibodies with non-immune lymphocytes.

Authors:  O Fakhri; J R Hobbs
Journal:  Nat New Biol       Date:  1972-02-09

4.  Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.

Authors:  P Perlmann; H Perlmann; H Wigzell
Journal:  Transplant Rev       Date:  1972

5.  Selective deficiency of cytotoxic B lymphocytes in man.

Authors:  A C Campbell; I C Maclennan; M L Snaith; I G Barnett
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

6.  Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.

Authors:  R J Winchester; J B Winfield; F Siegal; P Wernet; Z Bentwich; H G Kunkel
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

7.  Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia.

Authors:  A C Campbell; P Hersey; I C MacLennan; H E Kay; M C Pike
Journal:  Br Med J       Date:  1973-05-19

8.  Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus.

Authors:  M A Scheinberg; E S Cathcart; A L Goldstein
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

9.  Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants.

Authors:  A Basten; J F Miller; R Abraham
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.

Authors:  H B Dickler
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Systemic lupus erythematosus--an autoimmune disease?

Authors:  E J Holborow
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

4.  Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.

Authors:  S Kumagai; A D Steinberg; I Green
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

5.  Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis.

Authors:  S M Cooper; B Harding; G R Mirick; J Schneider; F P Quismorio; G J Friou
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  Natural killer cells and interferon responses in patients with systemic lupus erythematosus.

Authors:  G C Tsokos; A H Rook; J Y Djeu; J E Balow
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

7.  Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.

Authors:  J D Gray; A Lash; A C Bakke; R C Kitridou; D A Horwitz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

8.  Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.

Authors:  F Bortolotti; G Realdi; G Diodati; G Fattovich
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

9.  Cytotoxic responses to alloantigens in systemic lupus erythematosus.

Authors:  G C Tsokos; J E Balow
Journal:  J Clin Immunol       Date:  1981-10       Impact factor: 8.317

10.  Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Authors:  A Yamada; J B Winfield
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.